R O Brady, J N Kanfer, R M Bradley, D Shapiro
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | 2000 | 1999 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | 1971 | 1970 | 1969 | 1968 | 1967 | 1966 | 1960 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 4 | 4 | 6 | 6 | 9 | 19 | 17 | 9 | 3 | 13 | 5 | 8 | 6 | 11 | 12 | 4 | 2 | 7 | 10 | 7 | 4 | 7 | 3 | 1 | 3 | 3 | 1 | 1 | 3 | 4 | 1 | 4 | 1 | 1 | 3 | 1 | 2 | 4 | 3 | 3 | 1 | 3 | 2 | 5 | 8 | 3 | 8 | 9 | 8 | 9 | 7 | 10 | 7 | 7 | 3 | 1 | 1 | 308 |
Title and authors | Publication | Year |
---|---|---|
CNS expression of glucocerebrosidase corrects -synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
SP Sardi, J Clarke, C Kinnecom, TJ Tamsett, L Li, LM Stanek, MA Passini, GA Grabowski, MG Schlossmacher, RL Sidman, SH Cheng, LS Shihabuddin |
Proceedings of the National Academy of Sciences | 2011 |
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies
JM Aerts, WW Kallemeijn, W Wegdam, MJ Ferraz, MJ van Breemen, N Dekker, G Kramer, BJ Poorthuis, JE Groener, J Cox-Brinkman, SM Rombach, CE Hollak, GE Linthorst, MD Witte, H Gold, GA van der Marel, HS Overkleeft, RG Boot |
Journal of Inherited Metabolic Disease | 2011 |
Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.
Mollet-Boudjemline A, Hubert-Buron A, Boyer-Neumann C, Aldea R, Franco D, Trioche-Eberschweiller P, Mas AE, Mabille M, Labrune P, Gajdos V |
JIMD reports | 2011 |
Protective effect of recombinant human erythropoietin in type II Gaucher disease patient cells by scavenging endoplasmic reticulum stress
JR Cha, SJ Kim, TH Heo |
Biomedicine & Pharmacotherapy | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells
DH Yoon, OY Kwon, JY Mang, MJ Jung, DY Kim, YK Park, TH Heo, SJ Kim |
Biochemical and Biophysical Research Communications | 2011 |
Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress
YJ Lee, SJ Kim, TH Heo |
Biochemical and Biophysical Research Communications | 2011 |
Bone involvement as presenting sign of pediatric-onset Gaucher disease
L Rossi, F Zulian, J Stirnemann, TB de Villemur, N Belmatoug |
Joint Bone Spine | 2011 |
Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease
J Lu, C Yang, M Chen, DY Ye, RR Lonser, RO Brady, Z Zhuang |
Proceedings of the National Academy of Sciences | 2011 |
The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
W Benko, M Ries, EA Wiggs, RO Brady, R Schiffmann, EJ FitzGibbon, A Meisel |
PloS one | 2011 |
Successful screening for Gaucher disease in a high-prevalence population in tabuleiro do Norte (northeastern Brazil): a cross-sectional study.
Chaves RG, Coelho JC, Michelin-Tirelli K, Maurício TF, de Freitas Maia Chaves E, de Almeida PC, Maurício CR, Cavalcanti GB Jr |
JIMD reports | 2011 |